Kim Kwang-ho named to head Accuzen

Published: 2013-06-11 06:56:00

Updated: 2013-06-11 06:56:00

Accuzen, a local contrast media company and a subsidiary of Taejoon Pharmaceutical, said Monday it has appointed as its chief executive officer, Kim Kwang-ho, the former CEO of Boryung Pharmaceutical.

The new CEO boasts an impressive track record in the pharmaceutical industry as in the past h...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK